In-depth discussion on BCI at the intersection of neuroscience, engineering, and innovation
Brain-computer interfaces (BCIs) are rapidly moving from the realm of science fiction to real-world application, reshaping how humans interact with technology, restore lost function, and even augment cognition.
But where are we truly today, and what breakthroughs are just around the corner?
Join leading experts for an in-depth discussion at the intersection of neuroscience, engineering, and innovation.
Featuring:
- Philip Sabes, Cofounder, Integral Neurotechnologies
- Jun Axup Penman, Chief Operating Officer, E11 Bio
- Claire Nastaskin, Founding Member, Merge Labs
More speakers to be announced soon!
—
This panel will explore:
- The current state of BCI technologies—from implants to non-invasive approaches—and their respective trade-offs in performance, safety, and scalability
- Breakthrough applications in healthcare, including restoring movement, communication, and rehabilitation
- The role of AI and advanced data decoding in accelerating BCI capabilities
- Commercialization pathways: what it takes to move from lab research to viable products
- Ethical considerations, from data privacy to cognitive enhancement and human augmentation
Learn more about the Speakers
Philip Sabes is a neuroscientist and neurotechnology entrepreneur focused on developing tools to measure and modulate human brain circuits. He is co-founder of Integral Neurotechnologies.
Dr. Sabes was a Professor of Physiology at UCSF, where his lab combined neurophysiology, computation, and behavior to study how sensory feedback shapes movement and learning, including early demonstrations that artificial signals delivered via microstimulation can be incorporated into natural behavior.
His lab also developed advanced neural interface technologies, including optogenetic tools and a robotic system for inserting flexible, high-density electrode arrays. In 2017, Dr. Sabes co-founded Neuralink, where this approach was developed into a high-channel-count, fully implanted wireless brain–computer interface.
Dr. Sabes now focuses on developing next-generation neural interfaces for neurological and psychiatric disorders, including implantable systems for neuromodulation and experimental platforms for large-scale, causal studies of human brain circuits.
Jun Axup Penman is Chief Operating Officer at E11 Bio, a non-profit Focused Research Organization building scalable technologies for brain circuit mapping.
Previously, she was Chief Science Officer & Partner at IndieBio, a leading biotech startup accelerator for human and planetary health, where she advised over 160 companies, ran scientific programming, made investment decisions, and built community. She holds a Ph.D. in Chemical Biology from The Scripps Research Institute and worked at several biotech startups.
Dr. Claire Nastaskin is an expert in functional ultrasound imaging, an emerging neuroimaging modality that enables high-resolution, mapping of brain activity. She earned her PhD in Applied Physics from the Physics for Medicine Lab in Paris, France, a pioneering group behind the development of functional ultrasound imaging. Claire is currently a key contributor at Forest Neurotech, a nonprofit Focused Research Organization developing next-generation ultrasound-based BCIs to advance minimally invasive neurotechnology. She also holds a dual role with Merge Labs, a research organization focused on bridging biological and artificial intelligence to augment human capabilities.